Kenji Ishikura

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial

Kazumoto Iijima, Mayumi Sako, Kandai Nozu et al. · The Lancet · 2014 · 443 citations

Medicine, Nephrology, Pediatrics +14

Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease

Osamu Uemura, Takuhito Nagai, Kenji Ishikura et al. · Clinical and Experimental Nephrology · 2013 · 264 citations

Medicine, Nephrology, Pediatrics +16

A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment

Norishige Yoshikawa, Koichi Nakanishi, Mayumi Sako et al. · Kidney International · 2014 · 132 citations · Full text

Medicine, Nephrology, Pediatrics +14

ERK and p38 mediate high-glucose-induced hypertrophy and TGF-β expression in renal tubular cells

Hisayo Fujita, Sayu Omori, Kenji Ishikura et al. · American Journal of Physiology-Renal Physiology · 2004 · 125 citations

Life Sciences, Biochemistry, Cell Biology +15

Both the rituximab dose and maintenance immunosuppression in steroid-dependent/frequently-relapsing nephrotic syndrome have important effects on outcomes

Eugene Yu-hin Chan, Hazel Webb, E. Yu et al. · Kidney International · 2019 · 118 citations

Medicine, Immunology, Nephrology +12